Abstract
Gut microbiota has been recently established to have a contributory role in the development of cardiometabolic disorders, such as atherosclerosis, obesity, and type 2 diabetes. Growing interest has focused on the modulation of gut microbiota as a therapeutic strategy in cardiovascular diseases and metabolic disorders. In this paper, we have reviewed the impact of gut microbiota on metabolic disorders and cardiovascular disease risk, focusing on the newest findings in this field.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 120-120 |
| Numero di pagine | 1 |
| Rivista | Current Cardiology Reports |
| Volume | 17 |
| Numero di pubblicazione | 12 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2015 |
All Science Journal Classification (ASJC) codes
- Cardiologia e Medicina Cardiovascolare
Keywords
- Cardiovascular disease
- Gut microbiota
- Obesity
- Platelets
- Type 2 diabetes
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
